U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C29H33FN2O6.ClH
Molecular Weight 561.041
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ELGODIPINE HYDROCHLORIDE

SMILES

Cl.CC(C)OC(=O)C1=C(C)NC(C)=C(C1C2=C3OCOC3=CC=C2)C(=O)OCCN(C)CC4=CC=C(F)C=C4

InChI

InChIKey=JBKDMKOYLBVOOR-UHFFFAOYSA-N
InChI=1S/C29H33FN2O6.ClH/c1-17(2)38-29(34)25-19(4)31-18(3)24(26(25)22-7-6-8-23-27(22)37-16-36-23)28(33)35-14-13-32(5)15-20-9-11-21(30)12-10-20;/h6-12,17,26,31H,13-16H2,1-5H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C29H33FN2O6
Molecular Weight 524.5805
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Elgodipine (IQB-875, CAS 119413-55-7) is a phenyldihydropyridine derivative acting as a calcium channel antagonist. Elgodipine inhibited both T- and L-type calcium channels in a concentration-dependent manner. Elgodipine was in clinical trials for the treatment of cardiovascular diseases however its development has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Cardiovascular effects of elgodipine and nifedipine compared in anaesthetized rats.
1997 Sep 24
Patents

Sample Use Guides

Pharmacokinetic study: elgodipine was given as continuous infusion at various rates (5, 10, 15, 20, 40 microg/kg/h for 48, 48, 48, 24, or 6 h, respectively) to five groups of 6-12 healthy male subjects (total 42).
Route of Administration: Intravenous
In Vitro Use Guide
Elgodipine inhibited both T- and L-type calcium channels in a concentration-dependent manner. Half-inhibitions of T- and L-type calcium channel current were obtained at concentrations of 32 and 2.3 nM, respectively.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:56:16 GMT 2023
Edited
by admin
on Fri Dec 15 15:56:16 GMT 2023
Record UNII
MIR106H7SI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ELGODIPINE HYDROCHLORIDE
MI  
Common Name English
2-((P-FLUOROBENZYL)METHYLAMINO)ETHYL ISOPROPYL (±)- 1,4-DIHYDRO-2,6-DIMETHYL-4-(2,3-(METHYLENEDIOXY)PHENYL)-3,5-PYRIDINEDICARBOXYLATE HYDROCHLORIDE
Common Name English
ELGODIPINE HYDROCHLORIDE [MI]
Common Name English
IQB-875
Code English
3,5-PYRIDINEDICARBOXYLIC ACID, 4-(1,3-BENZODIOXOL-4-YL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-(2-(((4-FLUOROPHENYL)METHYL)METHYLAMINO)ETHYL) 5-(1-METHYLETHYL) ESTER, HYDROCHLORIDE (1:1)
Common Name English
3,5-PYRIDINEDICARBOXYLIC ACID, 4-(1,3-BENZODIOXOL-4-YL)-1,4-DIHYDRO-2,6-DIMETHYL-, 2-(((4-FLUOROPHENYL)METHYL)METHYLAMINO)ETHYL 1-METHYLETHYL ESTER, MONOHYDROCHLORIDE
Common Name English
Code System Code Type Description
CAS
121489-04-1
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY
MESH
C063839
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY
PUBCHEM
3078492
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY
MERCK INDEX
m1130
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY Merck Index
FDA UNII
MIR106H7SI
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID60923822
Created by admin on Fri Dec 15 15:56:16 GMT 2023 , Edited by admin on Fri Dec 15 15:56:16 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY